As a member of B7 family which consists of immune regulatory ligands, CD276 could modulate T lymphocyte activation and differentiation, recent studies have revealed that CD276 induces a robust immune evasive effect when deregulated in cancers. This evidence concerns the gene CD276 and cancer.